Sign In
Buy EVFM
$0.0080
+0.0015 (+23.08%)
At Close: Jun 03, 2026
Personalis Receives Contract Extension and New Task Order From the VA’s Million Veteran Program – Total Awarded to Date Now $175M
12:00am, Thursday, 17'th Sep 2020
Personalis Receives Contract Extension and New Task Order from the VA’s Million Veteran Program – Total Awarded to Date Now $175M
GP cash incentive linked to fall in UK abortion rates, study finds
06:00pm, Monday, 14'th Sep 2020
Use of long-acting reversible contraceptives rose due to scheme encouraging targeted advice to women
Evofem: Why I Bought Friday's Massive Spike Down
09:13am, Monday, 14'th Sep 2020
EVFM plunged from $3 to $2.1 in a two-day span, ostensibly on insider selling. The drop was on very large volume.
Do Options Traders Know Something About Evofem Biosciences (EVFM) Stock We Don't?
12:53pm, Tuesday, 11'th Aug 2020
Investors need to pay close attention to Evofem Biosciences (EVFM) stock based on the movements in the options market lately.
Despite Company Claims, Only A Fraction Of The Mountain Valley Pipeline Is Complete In Virginia
01:36pm, Monday, 10'th Aug 2020
It is a $6.2 billion corporate boondoggle that a Pittsburgh-based fracked gas company is trying to "ram down throats," the writer says.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evofem Biosciences (EVFM
Evofem Biosciences (NASDAQ:EVFM) Shares Gap Down on Disappointing Earnings
12:18am, Monday, 10'th Aug 2020
Evofem Biosciences Inc (NASDAQ:EVFM) gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $2.98, but opened
Evofem Biosciences, Inc. (EVFM) Q2 2020 Earnings Call Transcript | The Motley Fool
01:31am, Wednesday, 05'th Aug 2020
EVFM earnings call for the period ending June 30, 2020.
Evofem Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
12:00pm, Tuesday, 04'th Aug 2020
Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a commercial stage biopharmaceutical company, today reported financial results for the three- and six- month periods ended June 30
Equitrans Midstream Announces Second Quarter 2020 Results
12:00am, Tuesday, 04'th Aug 2020
Equitrans Midstream Corporation (NYSE: ETRN), today, announced financial and operational results for the second quarter 2020. Q2 2020 Highlights: Gene
Evofem Biosciences' CEO Saundra Pelletier Named to PharmaVOICE100 - The Most Inspiring People in Life Sciences
12:30pm, Monday, 03'rd Aug 2020
Evofem Biosciences, Inc. (NASDAQ: EVFM) is proud to announce that CEO Saundra Pelletier was named to the PharmaVOICE 100 Most Inspiring People, an annual list of the 100 most innovative, influential a
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Evofem Biosciences to Report Second Quarter 2020 Results and Provide Corporate Update on Tuesday, August 4, 2020
12:30pm, Thursday, 23'rd Jul 2020
Evofem Biosciences, Inc. (NASDAQ: EVFM) will hold a webcast and conference call to discuss the Company's financial results and business highlights for the second quarter ended June 30, 2020.
Edited Transcript of EVFM.OQ earnings conference call or presentation 6-Aug-19 3:00pm GMT
07:55am, Tuesday, 21'st Jul 2020
Q2 2019 Evofem Biosciences Inc Earnings Call
Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company, today announced that Contraception, an international, peer-reviewed, reproductive health journal, published the p
